We are looking for 2–17 years of age to join a Crohn’s disease (CD) medical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or Crohn’s (including associated symptoms such as fever, inflammation of the bowel or intestine, diarrhea, weight loss and/or eye pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
